Patent - Abbreviated New Drug Application Cases filed in Delaware
Cases 121 - 130 of 1,147
Pfizer Inc. et al v. Annora Pharma Private Limited et al
as 1:2023cv00634
Plaintiff: Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V. and others
Defendant: Annora Pharma Private Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan Holdings Unlimited Company et al v. Sun Pharmaceutical Industries Limited
as 1:2023cv00795
Plaintiff: Allergan Holdings Unlimited Company, AbbVie Inc., AbbVie US LLC and others
Defendant: Sun Pharmaceutical Industries Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan Holdings Unlimited Company et al v. MSN Laboratories Private Limited et al
as 1:2023cv00794
Plaintiff: Allergan Holdings Unlimited Company, AbbVie Inc., AbbVie US LLC and others
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court: Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant: ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Sandoz Inc. et al We have downloadable decisions or orders for this case
as 1:2020cv01589
Defendant: Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff: Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GmbH et al v. Indoco Remedies Limited et al
as 1:2023cv00690
Plaintiff: Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG and others
Defendant: Indoco Remedies Limited and FPP Holding Company LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx Corp.
as 1:2023cv00633
Plaintiff: Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals, Inc.
Defendant: BendaRx Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. v. Apotex Inc. et al
as 1:2023cv00775
Plaintiff: Gilead Sciences, Inc.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00732
Plaintiff: Biogen Inc., Biogen Swiss Manufacturing GmbH and Alkermes Pharma Ireland Limited
Defendant: Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
as 1:2023cv00583
Plaintiff: Vertex Pharmaceuticals Incorporated
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?